Overview: Pregnenolone TestIntroduction: The Pregnenolone Test measures pregnenolone to diagnose adrenal disorders, causing fatigue or hormonal issues. Following 2023 Endocrine Society guidelines, it uses biochemical methods for high specificity, supporting metabolic screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected adrenal insufficiency or congenital adrenal hyperplasia.
Other Names: Pregnenolone Assay, Adrenal Steroid Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Pregnenolone testing began in the 1980s with adrenal research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures pregnenolone to diagnose adrenal disorders, guides treatment, and evaluates patients with fatigue or hormonal issues.
Test Parameters: 1. Pregnenolone Level
Pretest Condition: Fasting for 10-12 hours required. Collect serum, plasma, or saliva. Report history of fatigue, hormonal issues, or adrenal symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fatigue, hormonal imbalances, or family history of adrenal disorders. Include current medications, especially corticosteroids.
Consent: Written consent required, detailing the tests purpose, adrenal disorder implications, and risks of sample collection.
Procedural Considerations: Uses liquid chromatography or immunoassays to measure pregnenolone levels. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for adrenal disorder diagnosis.
Factors Affecting Result Accuracy: Improper fasting or sample hemolysis can affect results. Medications like steroids may alter levels.
Clinical Significance: Abnormal pregnenolone levels confirm adrenal disorders, guiding hormone replacement or genetic testing. Normal results may require ACTH stimulation testing.
Specialist Consultation: Consult an endocrinologist for result interpretation and treatment planning.
Additional Supporting Tests: ACTH stimulation test, cortisol levels, or 17-hydroxyprogesterone to confirm adrenal disorder diagnosis.
Test Limitations: Non-specific for certain adrenal disorders; clinical correlation is needed. Sample quality affects sensitivity.
References: Endocrine Society Adrenal Guidelines, 2023; Journal of Clinical Endocrinology, Auchus RJ, 2022.
